🚀 VC round data is live in beta, check it out!
Youcare Pharmaceutical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Youcare Pharmaceutical and similar public comparables like MoonLake, ArriVent BioPharma, TOWA Pharmaceutical, Inhibrx Biosciences and more.
Youcare Pharmaceutical Overview
About Youcare Pharmaceutical
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
Founded
2001
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$1B
Youcare Pharmaceutical Financials
Youcare Pharmaceutical reported last fiscal year revenue of $359M and negative EBITDA of ($1M).
In the same fiscal year, Youcare Pharmaceutical generated $180M in gross profit, ($1M) in EBITDA losses, and had net loss of ($38M).
Youcare Pharmaceutical P&L
In the most recent fiscal year, Youcare Pharmaceutical reported revenue of $359M and EBITDA of ($1M).
Youcare Pharmaceutical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $359M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $180M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 50% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (0%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (8%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($38M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (11%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Youcare Pharmaceutical Stock Performance
Youcare Pharmaceutical has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Youcare Pharmaceutical's stock price is $2.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -3.6% | XXX | XXX | XXX | $-0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialYoucare Pharmaceutical Valuation Multiples
Youcare Pharmaceutical trades at 3.3x EV/Revenue multiple, and (1130.6x) EV/EBITDA.
Youcare Pharmaceutical Financial Valuation Multiples
As of April 18, 2026, Youcare Pharmaceutical has market cap of $1B and EV of $1B.
Equity research analysts estimate Youcare Pharmaceutical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Youcare Pharmaceutical has a P/E ratio of (34.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1130.6x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (42.1x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.6x | XXX | XXX | XXX |
| P/E | — | XXX | (34.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 39.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Youcare Pharmaceutical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Youcare Pharmaceutical Margins & Growth Rates
Youcare Pharmaceutical's revenue in the last fiscal year declined by (35%).
Youcare Pharmaceutical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (35%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (0%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (102%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 27% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 58% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Youcare Pharmaceutical Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Youcare Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| MoonLake | XXX | XXX | XXX | XXX | XXX | XXX |
| ArriVent BioPharma | XXX | XXX | XXX | XXX | XXX | XXX |
| TOWA Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Inhibrx Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| MapLight Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Youcare Pharmaceutical M&A Activity
Youcare Pharmaceutical acquired XXX companies to date.
Last acquisition by Youcare Pharmaceutical was on XXXXXXXX, XXXXX. Youcare Pharmaceutical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Youcare Pharmaceutical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialYoucare Pharmaceutical Investment Activity
Youcare Pharmaceutical invested in XXX companies to date.
Youcare Pharmaceutical made its latest investment on XXXXXXXX, XXXXX. Youcare Pharmaceutical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Youcare Pharmaceutical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Youcare Pharmaceutical
| When was Youcare Pharmaceutical founded? | Youcare Pharmaceutical was founded in 2001. |
| Where is Youcare Pharmaceutical headquartered? | Youcare Pharmaceutical is headquartered in China. |
| Is Youcare Pharmaceutical publicly listed? | Yes, Youcare Pharmaceutical is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Youcare Pharmaceutical? | Youcare Pharmaceutical trades under 688658 ticker. |
| When did Youcare Pharmaceutical go public? | Youcare Pharmaceutical went public in 2020. |
| Who are competitors of Youcare Pharmaceutical? | Youcare Pharmaceutical main competitors are MoonLake, ArriVent BioPharma, TOWA Pharmaceutical, Inhibrx Biosciences. |
| What is the current market cap of Youcare Pharmaceutical? | Youcare Pharmaceutical's current market cap is $1B. |
| What is the current revenue of Youcare Pharmaceutical? | Youcare Pharmaceutical's last fiscal year revenue is $359M. |
| What is the current EV/Revenue multiple of Youcare Pharmaceutical? | Current revenue multiple of Youcare Pharmaceutical is 3.3x. |
| Is Youcare Pharmaceutical profitable? | No, Youcare Pharmaceutical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.